SCHEMBL22322004

SCHEMBL22322004

CC(C)OP(=O)(Oc1ccccc1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.70
CA1 P00915 6/20 0.70
CA2 P00918 6/20 0.70
CA4 P22748 6/20 0.70
CA5A P35218 6/20 0.70
CA7 P43166 6/20 0.70
CA9 Q16790 6/20 0.70
CA5B Q9Y2D0 6/20 0.70
L3MBTL1 Q9Y468 3/20 0.68
TDP1 Q9NUW8 2/20 0.68
ALDH1A1 P00352 1/20 0.58
SRC P12931 1/20 0.44
ANPEP P15144 1/20 0.41
LAP3 P28838 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193997 0.86 L3MBTL1 (0.69) CA12CA1CA2CA4CA5A
SCHEMBL7623138 0.86 L3MBTL1 (0.63) CA12CA1CA2CA4CA5A
SCHEMBL2608782 0.84 L3MBTL1 (0.61) CA12CA1CA2CA4CA5A
SCHEMBL561190 0.82 L3MBTL1 (1.00) CA12CA1CA2CA4CA5A
SCHEMBL20704090 0.81 L3MBTL1 (0.62) CA12CA1CA2CA4CA5A
SCHEMBL9469076 0.81 L3MBTL1 (0.61) CA12CA1CA2CA4CA5A
SCHEMBL2535071 0.79 L3MBTL1 (0.53) CA12CA1CA2CA4CA5A
SCHEMBL1028971 0.79 L3MBTL1 (0.53) CA12CA1CA2CA4CA5A
SCHEMBL976099 0.79 L3MBTL1 (0.76) CA12CA1CA2CA4CA5A
SCHEMBL407307 0.78 L3MBTL1 (0.61) CA12CA1CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 CA12 3108/4885CA1 2467/4885CA2 1238/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 CA12 3108/4885CA1 2467/4885CA2 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.